Multiscale Topological Transcriptomic Analysis for Alzheimer’s Disease Drug Repurposing
Journal of Chemical Information and Modeling · 20.11.2026
DOI: 10.1021/acs.jcim.6c03396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 20.11.2026. Verfasst von Guilin Wang und 3 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a complex neurodegenerative disorder driven by multifactorial molecular mechanisms, which severely limit the efficacy of current therapeutic interventions. To accelerate the discovery of novel treatments, we propose a comprehensive computational framework integrating transcriptomic analysis, topological network characterization, machine learning (ML), and structure-based evaluation. By analyzing eight independent AD transcriptomic datasets, we constructed protein–protein interaction networks and implemented a multiscale topological differentiation strategy based on persistent homology and persistent spectral theory. This approach quantified the topological importance of each gene, prioritizing 67 nonredundant key genes. To bridge target identification with drug screening, we mapped these genes to the ChEMBL database, yielding 4,493 bioactivity records across five primary targets. We evaluated three ML algorithms across diverse molecular representations, including two natural language processing-derived molecular embeddings and a conventional molecular fingerprint. Deploying these predictive models for large-scale virtual screening of the DrugBank database yielded several promising repurposing candidates. Subsequent molecular docking against the target proteins GLP1R and CASP1 generated predicted binding poses for selected compounds. Physicochemical profiling identified differences relevant to their further assessment, although these computational results do not establish binding stability, pharmacokinetic suitability, or safety. This study not only identifies viable therapeutic candidates for AD but also provides a scalable, generalizable pipeline for target prioritization and drug discovery applicable to other complex human diseases.
Zitieren
APA
Wang, G., Wang, Z., Wei, X., & Jiang, J. (2026). Multiscale Topological Transcriptomic Analysis for Alzheimer’s Disease Drug Repurposing. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.6c03396
Vancouver
Wang G, Wang Z, Wei X, Jiang J. Multiscale Topological Transcriptomic Analysis for Alzheimer’s Disease Drug Repurposing. Journal of Chemical Information and Modeling. 2026. doi:10.1021/acs.jcim.6c03396
BibTeX
@article{Wang2026,
author = {Wang, Guilin and Wang, Zihan and Wei, Xiaoqi and Jiang, Jian},
title = {Multiscale Topological Transcriptomic Analysis for Alzheimer’s Disease Drug Repurposing},
journal = {Journal of Chemical Information and Modeling},
year = {2026},
doi = {10.1021/acs.jcim.6c03396}
}
EUVIMED